# Eloxx Pharmaceuticals, Inc.: Form S-1, filed Sep 11, 2026

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: S-1
- Filed: 2026-09-11
- Accepted by EDGAR: Sep 11, 2026, 17:28 ET
- Period: not reported
- Accession: 0001193125-26-389422
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000119312526389422/d152186ds1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000119312526389422/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000119312526389422/d152186ds1.htm

Filed Sep 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-389422. Last ingested by Listed: Nov 15, 2026, 04:18 ET. No prices; not investment advice.
